The Financial Supervision Commission confirmed the prospectus for a secondary public offering of shares of Etropal Jsc. The issue's value stands at 5 mln leva allocated in as many shares with a face value of 1 lev each and representing the company's registered capital.

Etropal Jsc is a leading manufacturer of disposable medical supplies. The company is a unit of Eurohold Bulgaria, which controls 93.71% of its capital.

Etropal Jsc group also includes 7 subsidiaris: Etropal Trade, Dialysis Center Etropal, Dialysis Etropal Alfa, Dialysis Etropal Beta, Dialysis Etropal Delta, Dialysis Etropal Delta, Dialysis Etropal Gama, Dialysis Etropal Sigma.

In the last quarter Etropal Jsc founded two joint companies – IB Medica in Bulgaria and Fibra in Italy, the latter is founded in cooperation with local partners.

Etropal expects 2007 consolidated revenues to top 20 mln leva (10.225 mln euros), versus 10.7 mln leva (5.470 mln euros) in 2006.